YUFLYMA

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Germany, Ireland, Italy, Lithuania, Poland, Romania, UK.

Active ingredients

The drug YUFLYMA contains one active pharmaceutical ingredient (API):

1	Adalimumab UNII FYS6T7F842 - ADALIMUMAB
	Adalimumab binds specifically to TNF and neutralizes the biological function of TNF by blocking its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also modulates biological responses that are induced or regulated by TNF, including changes in the levels of adhesion molecules responsible for leukocyte migration (ELAM-1, VCAM-1, and ICAM-1 with an IC50 of 0.1-0.2 nM).
	Read more about Adalimumab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
YUFLYMA 40 mg Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AB04	Adalimumab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	16847684, 16847709, 16847721, 16847744, 17576483, 17576508, 17583678, 17583684, 17824805, 17824834, 17856107, 17856113, 17869788, 17869794, 17896420, 17896437, 17896466, 17896472
EE	Ravimiamet	1841116, 1841127, 1841138, 1841149, 1841150, 1841161, 1841172, 1841183, 1841194, 1841206, 1841217, 1841228
FI	Lääkealan turvallisuus- ja kehittämiskeskus	120167, 460719, 478857, 491693, 594328
FR	Base de données publique des médicaments	64175717, 65075488, 65597237, 66691223, 67478840
GB	Medicines & Healthcare Products Regulatory Agency	395838, 395840
IE	Health Products Regulatory Authority	89110
IT	Agenzia del Farmaco	049376015, 049376027, 049376039, 049376041, 049376054, 049376066, 049376078, 049376080, 049376092, 049376104, 049376116, 049376128, 049376130, 049376142, 049376155, 049376167, 049376179
LT	Valstybinė vaistų kontrolės tarnyba	1092101, 1092102, 1092103, 1092104, 1092105, 1092106, 1092107, 1092108, 1092109, 1092110, 1092111, 1092112
PL	Rejestru Produktów Leczniczych	100448648, 100448660
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67468001, W67468002, W67468003, W67468004, W67468005, W67468006, W67468007, W67468008, W67469001, W67469002, W67469003, W67469004, W69241001, W69241002, W69242001, W69242002